Triventures
Est. dry powder
—
Not reported
AUM
$200M
Assets under management
Latest fund
—
Triventures ARC By Sheba, size not reported
Est. cheque size
$437.5K–
From fund sizes
Deals, last 12 months
—
Not reported
About Triventures
Triventures is an Israel based private equity firm that focuses on investing and developing early-stage, seed-stage investments in healthcare, and medical technology opportunities. The firm specifically targets innovative Israeli-related medical device companies across US, Europe and Israel.
- Type
- Venture Capital Firm
- Headquarters
- Tel Aviv, Israel
- Stages
- SeedSeries ASeries BSeries CSeries DEarly Stage
- Est. cheque size
- $437.5K–$4.1M
- Sectors
- Healthcare, Information Technology
- Regions
- Middle East
- Strategies
- Seed, Pre-Seed, Series A
Where they invest
From deals and portfolio companies on record
Most frequent rounds
- Series B12
- Series A10
- Series C10
- Seed7
- Series D1
Across 50 deals
Portfolio sectors
- Medical Devices & Equipment12
- Healthcare IT5
- Software3
- Healthcare Specialists2
- Biotechnology1
Across 27 companies
Portfolio countries
- US16
- Israel10
- Ireland1
Across 27 companies
Recent investments
Newest 5 of 50
- Seed$35M
Descope Inc.
Oct 2025 · Seed
- Series B—
FEMSelect Ltd.
May 2025 · Series B
- Unspecified Round—
TailorMed Medical Inc.
Nov 2024 · Unspecified Round
- Unspecified Round—
Get-Grin Inc.
Oct 2024 · Unspecified Round
- Series A$27M
Monogoto Inc.
Oct 2024 · Series A
Offices
2 locations
- Tel Aviv, IsraelHQ
- Portola Valley, California, US
Questions about Triventures
How much does Triventures invest per deal?
Based on the size of its funds, Triventures writes estimated cheques of $437.5K–$4.1M. Lead cheques usually sit at the top of that range and follow-on cheques lower.
What stages does Triventures invest in?
Triventures has invested at Seed, Series A, Series B, Series C, Series D and Early Stage. Its most frequent rounds on record are Series B, Series A and Series C.
What has Triventures invested in recently?
Recent investments include Descope Inc., FEMSelect Ltd. and TailorMed Medical Inc..